Loading…
Fierce Drug Dev Forum 2019 has ended
Back To Schedule
Monday, October 28 • 2:00pm - 2:45pm
Explore How AI and Machine Learning Can Be the Backbone to Building a Hypothesis for Drug Discovery

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
  • Highlight the major challenges, as well as misconceptions, to overcome in realizing the benefits of AI in drug discovery/pharma
  • Review some examples of successful implementation of AI methods in hypothesis generation in drug discovery
  • Explore some exciting areas for AI in drug discovery that are not quite ready for prime time, but are advancing quickly
  • Discuss how startups and pharma can work together to innovate in this space

Speakers
avatar for Roman Yelensky

Roman Yelensky

Executive Vice President and Chief Technology Officer, GRITSTONE ONCOLOGY
Roman Yelensky, Ph.D. has served as our Executive Vice President, Chief Technology Officer since October 2015. He joined Gritstone at its inception in October 2015 as executive vice president of sequencing and bioinformatics. Prior to Gritstone, from July 2010 to September 2015, Dr... Read More →
avatar for Nicolas Stransky

Nicolas Stransky

Senior Director, Head of Data Science, CELSIUS THERAPEUTICS
avatar for Dr. Josep Bassaganya-Riera

Dr. Josep Bassaganya-Riera

Chairman and CEO, LANDOS BIOPHARMA
Dr. Josep Bassaganya-Riera, Chairman and CEO of Landos Biopharma, is an innovator, serial entrepreneur & thought leader in biotech. He has published over 200 peer-reviewed publications & patents and has founded 3 award-winning companies, raising over $125 million in non-dilutive and... Read More →
avatar for Pat Walters

Pat Walters

Senior Vice President, Computation, RELAY THERAPEUTICS
Pat Walters heads the Computation & Informatics group at Relay Therapeutics. This group focuses on novel applications of computational methods that integrate computer simulations and experimental data to provide insights that drive drug discovery programs. Prior to joining Relay... Read More →
avatar for Ron Alfa

Ron Alfa

Vice President of Translational Research, RECURSION PHARMACEUTICALS
Ron is Senior Vice President, Translational Discovery at Recursion (recursionpharma.com), a technology-enabled drug discovery company combining machine learning with automated cell biology. At Recursion, his team manages commercial and translational strategy for Recursion’s portfolio... Read More →

Monday October 28, 2019 2:00pm - 2:45pm PDT
  Product Development Strategy